VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 128 filers reported holding VERVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $563,550 | -60.3% | 42,500 | -43.8% | 0.00% | -100.0% |
| Q2 2023 | $1,418,813 | +24.9% | 75,670 | -3.9% | 0.00% | – |
| Q1 2023 | $1,135,863 | -25.6% | 78,770 | -0.1% | 0.00% | -100.0% |
| Q4 2022 | $1,526,135 | -39.8% | 78,870 | +6.9% | 0.00% | 0.0% |
| Q3 2022 | $2,534,000 | +312.7% | 73,770 | +83.5% | 0.00% | – |
| Q2 2022 | $614,000 | -21.1% | 40,200 | +17.9% | 0.00% | – |
| Q1 2022 | $778,000 | +52.8% | 34,100 | +147.1% | 0.00% | – |
| Q4 2021 | $509,000 | -32.3% | 13,800 | -13.8% | 0.00% | – |
| Q3 2021 | $752,000 | +100.5% | 16,000 | +157.3% | 0.00% | – |
| Q2 2021 | $375,000 | – | 6,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |